(Q41463764)

1 October 2017

title

Regulation of Treg-associated CD39 in multiple sclerosis and effects of corticotherapy during relapse (English)

1 reference

1 October 2017

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662347%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Nathalie G V Muls

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662347%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Hong Anh Dang

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662347%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Christian J M Sindic

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662347%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

publication date

6 February 2015

1 reference

Multiple Sclerosis Journal

1 October 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662347%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662347%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662347%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

1533-1545

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662347%20AND%20SRC:MED&resulttype=core&format=json

Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis

2 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458514567215

Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514567215

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514567215

DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514567215

Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514567215

Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514567215

Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies: posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514567215

Increased memory Th17 cells in patients with neuromyelitis optica and multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514567215

Immunology of relapse and remission in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514567215

Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514567215

Self-tolerance in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514567215

Immunoregulatory T cells in multiple sclerosis and the effect of interferon beta and glatiramer acetate treatment on T cell subpopulations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514567215

Fingolimod modulates peripheral effector and regulatory T cells in MS patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514567215

Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514567215

Decreased FOXP3 levels in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514567215

Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514567215

Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514567215

Glucocorticoids increase CD4CD25 cell percentage and Foxp3 expression in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514567215

Influence of short-term glucocorticoid therapy on regulatory T cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514567215

Role of mitochondrial glucocorticoid receptor in glucocorticoid-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514567215

Peripheral T cells are the therapeutic targets of glucocorticoids in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514567215

The inflammasomes: guardians of the body

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514567215

CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514567215

T regulatory cells are markers of disease activity in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514567215

Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514567215

Regulation of aryl hydrocarbon receptor expression and function by glucocorticoids in mouse hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514567215

The inhibitory cytokine IL-35 contributes to regulatory T-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514567215

IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514567215

Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514567215

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514567215

21 January 2018

Identifiers

DOI

10.1177/1352458514567215

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25662347%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1 reference